Key facts
- PALMISANO ROBERT J filed SCHEDULE 13D/A for AEON Biopharma, Inc. Class A Common Stock (AEON).
- Disclosed ownership: 5.7%.
- Date of event: 25 Jul 2024.
PALMISANO ROBERT J - 25 Jul 2024 SCHEDULE 13D/A Report for AEON Biopharma, Inc. Class A Common Stock (AEON)
- Filing Manager
- PALMISANO ROBERT J
- Reporting Manager
- Robert J Palmisano
- Symbol
- AEON
- Shares outstanding
- 39,736,842 shares
- Disclosed Ownership
- 2,265,000 shares
- Ownership
- 5.7%
- Form type
- SCHEDULE 13D/A
- Filing time
- 07 Mar 2025, 16:01:43 UTC
- Date of event
- 25 Jul 2024
- SEC
- View on sec.gov
Key filing fact
PALMISANO ROBERT J disclosed 5.7% ownership in AEON Biopharma, Inc. Class A Common Stock (AEON) on 25 Jul 2024.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 07 Mar 2025, 16:01.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (2)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Robert J Palmisano | 5.7% | 2,265,000 | 2,265,000 | 0 | /s/ Robert J. Palmisano | Robert J. Palmisano | 0001138646 |
| The Palmisano Family, LLC | 5.7% | 2,265,000 | 2,265,000 | 0 | /s/ Robert J Palmisano | Robert J Palmisano/Manager |
CIK / CUSIP context first